Lupin Launches Dapagliflozin Tablets in the United States

MUMBAI, India and NAPLES, Fla., April 10, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of Dapagliflozin Tablets, 5 mg and 10 mg, in the United States following the...